Open access
Open access
Powered by Google Translator Translator

M-A | Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease.

7 Jul, 2022 | 12:34h | UTC

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis – Journal of Neurology Neurosurgery & Psychiatry

Commentaries:

Expert reaction to systematic review and meta-analysis looking at the evidence of whether noradrenergic drugs may be able to treat symptoms of Alzheimer’s disease – Science Media Centre

Noradrenergic drugs could be repurposed to offer effective treatment for Alzheimer’s disease symptoms – BMJ / News Medical

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.